Steris | STE - Sales Revenues


Steris reported $1.5B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
3M USD 6.1B 200M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
CONMED USD 373.2M 35.3M Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Dexcom USD 1.26B 50M Dec/2025
Ecolab USD 4.19B 20M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Fortive USD 1.12B 90M Dec/2025
Getinge SEK 11.07B 3.2B Dec/2024
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Olympus JPY 261.05B 13.21B Dec/2025
Orthofix International USD 799.49M 602.88M Dec/2024
Owens Minor USD 697.26M 15.36M Sep/2025
ResMed USD 1.4B 100M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025